Università LUM Giuseppe Degennaro - sito della Ricerca Institutional Research Information System

ROCCA, BIANCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.703
NA - Nord America 3.048
SA - Sud America 2.420
EU - Europa 731
AF - Africa 380
Continente sconosciuto - Info sul continente non disponibili 253
OC - Oceania 9
Totale 10.544
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.864
BR - Brasile 1.891
SG - Singapore 1.099
VN - Vietnam 1.038
CN - Cina 884
MA - Marocco 251
AR - Argentina 221
HK - Hong Kong 167
IT - Italia 154
DE - Germania 139
ID - Indonesia 136
EC - Ecuador 111
BD - Bangladesh 92
PK - Pakistan 89
MX - Messico 74
GB - Regno Unito 71
RU - Federazione Russa 67
FR - Francia 66
IN - India 63
CO - Colombia 57
CA - Canada 55
ZA - Sudafrica 48
PY - Paraguay 43
AT - Austria 42
CL - Cile 31
FI - Finlandia 28
NL - Olanda 28
ES - Italia 23
VE - Venezuela 23
PE - Perù 21
UA - Ucraina 21
EG - Egitto 20
IQ - Iraq 16
PL - Polonia 16
DZ - Algeria 15
KE - Kenya 15
JP - Giappone 14
BG - Bulgaria 13
TR - Turchia 13
TN - Tunisia 12
UY - Uruguay 12
DO - Repubblica Dominicana 11
UZ - Uzbekistan 11
KZ - Kazakistan 10
PH - Filippine 10
BO - Bolivia 9
SA - Arabia Saudita 9
AL - Albania 8
AU - Australia 8
CR - Costa Rica 8
SE - Svezia 7
SV - El Salvador 7
EE - Estonia 6
HN - Honduras 6
AZ - Azerbaigian 5
KR - Corea 5
MD - Moldavia 5
PA - Panama 5
RO - Romania 5
SN - Senegal 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
CU - Cuba 4
GT - Guatemala 4
IL - Israele 4
JM - Giamaica 4
MY - Malesia 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
BE - Belgio 3
BH - Bahrain 3
CH - Svizzera 3
JO - Giordania 3
KW - Kuwait 3
MK - Macedonia 3
PS - Palestinian Territory 3
RS - Serbia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
CG - Congo 2
ET - Etiopia 2
IE - Irlanda 2
KG - Kirghizistan 2
KH - Cambogia 2
LT - Lituania 2
OM - Oman 2
PT - Portogallo 2
BF - Burkina Faso 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
Totale 10.277
Salva come PNG Salva come JPEG
Città #
Dallas 1.236
Singapore 558
Ho Chi Minh City 400
Ashburn 307
San Jose 272
The Dalles 261
Hefei 228
Casablanca 225
Hanoi 196
Hong Kong 164
São Paulo 158
Beijing 141
Santa Clara 84
Islamabad 71
Columbus 64
New York 62
Rio de Janeiro 55
Haiphong 48
Los Angeles 46
Guayaquil 39
Da Nang 38
Frankfurt am Main 38
Curitiba 37
Chicago 31
Munich 31
Rome 31
Belo Horizonte 30
Biên Hòa 29
Quito 29
Brasília 28
Milan 26
Thái Bình 24
Helsinki 23
Hải Dương 22
Orem 22
Porto Alegre 22
Buenos Aires 20
Campinas 20
Ninh Bình 20
Mexico City 19
Jakarta 18
Piracicaba 18
Amsterdam 17
Asunción 17
Barnet 17
Ha Long 17
Johannesburg 17
Toronto 17
Fortaleza 16
Guarulhos 16
Nuremberg 16
Chennai 15
Phoenix 15
Sorocaba 15
Can Tho 14
Salvador 14
Vienna 14
Bắc Giang 13
Montreal 13
São José do Rio Preto 13
Bắc Ninh 12
Cairo 12
Dhaka 12
Moscow 12
Nairobi 12
Thái Nguyên 12
Viamão 12
Council Bluffs 11
Hillsboro 11
Osasco 11
Phủ Lý 11
Recife 11
Ribeirão Preto 11
Tokyo 11
Bogotá 10
Goiânia 10
Hortolândia 10
London 10
Montevideo 10
Naples 10
Rabat 10
Surabaya 10
Warsaw 10
Brooklyn 9
Duque de Caxias 9
Durban 9
Itapevi 9
Manaus 9
Nova Friburgo 9
Rio Claro 9
Roubaix 9
Santos 9
Sumaré 9
Tashkent 9
Bauru 8
Blumenau 8
Boston 8
Catanduva 8
Chapecó 8
Diadema 8
Totale 5.865
Salva come PNG Salva come JPEG
Nome #
Management of cancer-associated venous thromboembolism: Perspectives on optimizing current therapeutics with a focus on factor XI inhibition 266
Rethinking aspirin responsiveness in coronary surgery: True resistance or misinterpretation 195
2025 ESC/EACTS Guidelines for the management of valvular heart disease 189
2025 ESC/EACTS Guidelines for the management of valvular heart disease 172
Cardio-oncology: Emerging Concepts in Cardiovascular Sequelae of Cancer Therapies, Translational Research and Reverse Cardio-oncology 110
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) 101
2024 EACTS Guidelines on perioperative medication in adult cardiac surgery 91
Stress-induced salivary cortisol secretion during hypobaric hypoxia challenge and in vivo urinary thromboxane production in healthy male subjects 88
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases 85
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy 82
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) 81
Prolonged fasting promotes systemic inflammation and platelet activation in humans: A medically supervised, water-only fasting and refeeding study 80
2024 EACTS guidelines on perioperative medication in adult cardiac surgery: embracing precision medicine driven by strong evidence-based methodology 74
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 72
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 72
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer 70
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 67
2023 ESC Guidelines for the management of acute coronary syndromes 66
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes 65
Acceptability of aspirin for cancer preventive therapy: a survey and qualitative study exploring the views of the UK general population 65
Aspirin, stroke and drug-drug interactions 64
Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH 63
A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation 62
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 60
A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes 60
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA) 58
Prostaglandins and other eicosanoids 58
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes in low-resource settings 57
Effects of low-dose rivaroxaban combined with low-dose aspirin versus low-dose aspirin alone on in vivo platelet activation, endothelial function and inflammation in type 2 diabetes patients with stable atherosclerotic disease: the RivAsa randomized, crossover study 57
Abnormal Megakaryopoiesis and Platelet Function in Cyclooxygenase-2-Deficient Mice 56
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 56
Polycythemia Vera: the natural history of 1213 patients followed for 20 years 55
A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation 55
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: A joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA) 55
Reprogramming Epigenetic Changes Blunts p66Shc-induced Vascular Dysfunction In Experimental and Human Obesity: Insights for Mechanisms-Based Therapeutic Strategies 55
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis 54
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 53
Infective Endocarditis and Antithrombotic Therapy 52
Aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: A new perspective 52
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC 52
Characterization of aspirin esterase activity in health and disease: In vitro and ex vivo studies 52
Platelet reactivity in patients with stable cardiovascular disease using aspirin: correlation between different tests and association with subject characteristics 52
Characterization of aspirin esterase activity in health and disease: In vitro and ex vivo studies 52
Platelet and megakaryocyte phenotypes of COX-2 deletion 52
Platelet progenitors: the hidden drug target 51
The lifespan determinant p66shc drives obesity-induced oxidative stress, mitochondrial dysfunction and vascular inflammation 51
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer 51
Ticagrelor and Statins: Dangerous Liaisons? 51
Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation 51
Safety of Antithrombotic Agents in Elderly Patients with Acute Coronary Syndromes 51
EQUIVALENZE DI CLASSE TE RAPEUTICA NELL'AREA DEGLI ANTICOAGULANTI ORALI 51
In Vivo Platelet Activation in Impaired Glucose Tolerance and During Progression of Type 2 Diabetes: a Cross-sectional and Longitudinal Study 51
Update on antithrombotic therapy and body mass. A Clinical consensus Statement of the ESC Working Group on Cardiovascular Pharmacotherapy and the ESC Working Group on Thrombosis 50
Antithrombotic therapy and revascularisation strategies in people with diabetes and coronary artery disease 50
Effect of very long-term storage and multiple freeze and thaw cycles on 11-dehydro-thromboxane-B2 and 8-iso-prostaglandin F2α, levels in human urine samples by validated enzyme immunoassays 50
Kinetics of free platelet decrease after ADP: effect of fibrinogen binding inhibitors 50
Pseudo-acquired vWD in essential thrombocythemia: the role of platelets 50
Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count 50
Clinical guidelines for a dry land: challenges in developing recommendations for DOAC management in emergent cardiac surgery 49
Heat extremes and cardiovascular diseases: a scientific statement of the Association of Cardiovascular Nursing & Allied Professions, Association for Acute Cardiovascular Care, European Association of Preventive Cardiology, Heart Failure Association, European Heart Rhythm Association of the ESC, the ESC Council on Hypertension, the ESC Council on Stroke, and the ESC Working Group on Cardiovascular Pharmacotherapy 49
Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing 49
Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation 49
Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia 49
Factor XI and Atrial Fibrillation: A Mismatched Pairing? 48
Twice Daily Dosing Normalyzes the Impaired Antiplatelet Effect of Low-Dose Aspirin Due to Enhanced Platelet Turnover in Patients Undergoing On-Pump Cardiac Surgery 48
In Silico Modeling of the Antiplatelet Pharmacodynamics of Low-dose Aspirin in Health and Disease 47
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 47
Management of dyslipidaemia in patients with comorbidities—facing the challenge: type 1 diabetes mellitus 46
Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus 46
The ESC Working Group on Cardiovascular Pharmacotherapy: continuity through transformation 46
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design - implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting. (Rocca B and De Stefano V co-first Authors) 45
Effect of low-dose and standard-dose aspirin on PGE2 biosynthesis among individuals with colorectal adenomas: A randomized clinical trial 45
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 45
Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Acute Cardiovascular Care Association (ACCA), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart Diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular Diseases, WG e-Cardiology, WG Thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS) 45
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome 45
Aspirin for primary prevention: new scores for old questions? 45
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis 45
Genetic Deletion of P66 (Shc) Protects Against Obesity-Induced Mitochondrial Dysfunction, Oxidative Stress and Vascular Inflammation 45
Low-dose aspirin in polycythaemia vera: A pilot study 45
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 45
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial 45
Expression and activity of cyclooxygenase isoforms in skeletal muscles and myocardium of humans and rodents 44
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector 44
Farmaci antipiastrinici 44
Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis 44
The Key Contribution Of Platelet And Vascular Arachidonic Acid Metabolism To The Pathophysiology Of Atherothrombosis 43
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a Joint Position Paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI) 43
Thromboxane biosynthesis and future events in diabetes: the ASCEND trial 43
Directed vascular expression of the thromboxane A2 receptor results in intrauterine growth retardation 42
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 42
Pathophysiology of Thrombosis in Peripheral Artery Disease 42
Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and Haemostasis 42
Distinct expression of Cyclooxygenase-1 and –2 in the human thymus 42
Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease 42
Increased Von Willebrand Factor levels in Polycythemia Vera and phenotypic differences with Essential Thrombocythemia 42
Nonsteroidal Antiinflammatory Drugs: Past, Present and Future 41
Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis 41
Aspirin: promise and resistance in the new millennium 41
Stability of urinary thromboxane A2 metabolites and adaptation of the extraction method to small urine volume 41
Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo 40
Totale 6.012
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.633
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.633
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.362 0 0 0 343 104 91 22 52 199 166 236 149
2025/20268.889 242 1.074 1.894 2.978 171 120 641 519 396 562 191 101
2026/2027293 142 151 0 0 0 0 0 0 0 0 0 0
Totale 10.544